DEERFIELD MANAGEMENT COMPANY, L.P. Q2 2026 Filing
Filed August 14, 2026
Portfolio Value
$6.0T
Holdings
82
Report Date
Q2 2026
Filing Type
13F-HR
All Holdings (82 positions)
| Stock | Value |
|---|---|
BKD 3.5 10/15/29BROOKDALE SR LIVING INC | $585.7B |
VTRSVIATRIS INC | $320.9B |
CNCCENTENE CORP DEL | $314.6B |
—REVOLUTION MEDICINES INC | $251.7B |
—ARROWHEAD PHARMACEUTICALS IN | $240.5B |
LEGNLEGEND BIOTECH CORP | $235.0B |
COGTCOGENT BIOSCIENCES INC | $193.7B |
GMABGENMAB A/S | $188.6B |
B7SBROOKDALE SR LIVING INC | $187.2B |
VERAVERA THERAPEUTICS INC | $168.1B |
ISIIONIS PHARMACEUTICALS INC | $157.0B |
BCRXBIOCRYST PHARMACEUTICALS INC | $151.0B |
NAMSNEWAMSTERDAM PHARMA COMPANY | $144.5B |
ACHCACADIA HEALTHCARE COMPANY IN | $133.5B |
TNGXTANGO THERAPEUTICS INC | $131.0B |
AHCOADAPTHEALTH CORP | $119.6B |
PHVSPHARVARIS N V | $116.7B |
—CELCUITY INC | $113.8B |
ARWRARROWHEAD PHARMACEUTICALS IN | $113.2B |
DNTHDIANTHUS THERAPEUTICS INC | $109.7B |
LRMRLARIMAR THERAPEUTICS INC | $108.6B |
MLYSMINERALYS THERAPEUTICS INC | $106.8B |
ALHC 4.25 11/15/29ALIGNMENT HEALTHCARE INC | $103.8B |
IDYAIDEAYA BIOSCIENCES INC | $101.2B |
XENEXENON PHARMACEUTICALS INC | $97.5B |
IONS 1.75 06/15/28IONIS PHARMACEUTICALS INC | $93.1B |
YB4PSAVARA INC | $83.6B |
SNDXSYNDAX PHARMACEUTICALS INC | $82.6B |
—ZENAS BIOPHARMA INC | $80.3B |
BMRNBIOMARIN PHARMACEUTICAL INC | $76.3B |
PFEPFIZER INC | $73.2B |
INDVINDIVIOR PHARMACEUTICALS INC | $67.7B |
SPRYARS PHARMACEUTICALS INC | $60.1B |
STOKSTOKE THERAPEUTICS INC | $59.7B |
GPCRSTRUCTURE THERAPEUTICS INC | $58.3B |
NVSTENVISTA HOLDINGS CORPORATION | $58.2B |
INSPINSPIRE MED SYS INC | $57.9B |
CDNACAREDX INC | $56.9B |
BSXBOSTON SCIENTIFIC CORP | $56.1B |
—PARABILIS MEDICINES INC | $51.5B |
CERTCERTARA INC | $49.2B |
IRONDISC MEDICINE INC | $48.1B |
LIVN 2.5 03/15/29LIVANOVA PLC | $46.5B |
BBOTBRIDGEBIO ONCOLOGY THERAPEUT | $37.2B |
TYRATYRA BIOSCIENCES INC | $32.5B |
MNPRMONOPAR THERAPEUTICS INC | $30.0B |
SIONSIONNA THERAPEUTICS INC | $30.0B |
IMCR 2.5 02/01/30IMMUNOCORE HLDGS PLC | $27.1B |
—AVALYN PHARMACEUTICALS INC | $24.1B |
FHTXFOGHORN THERAPEUTICS INC | $21.4B |
BBNXBETA BIONICS INC | $20.7B |
DRUGBRIGHT MINDS BIOSCIENCES INC | $19.9B |
—ODYSSEY THERAPEUTICS INC | $19.6B |
TOITHE ONCOLOGY INSTITUTE INC | $18.2B |
KYTXKYVERNA THERAPEUTICS INC | $17.8B |
—ALAMAR BIOSCIENCES INC | $16.3B |
—SPYGLASS PHARMA INC | $12.2B |
NEO 0.25 01/15/28NEOGENOMICS INC | $12.2B |
ADAGADAGENE INC | $11.2B |
—HEMAB THERAPEUTICS HLDGS INC | $10.1B |
—MOBIA MED INC | $9.0B |
EMBCEMBECTA CORP | $8.3B |
VCYTVERACYTE INC | $5.9B |
ANNXANNEXON INC | $3.3B |
NUVLNUVALENT INC | $2.1B |
ALECALECTOR INC | $2.1B |
NAMSNEWAMSTERDAM PHARMA COMPANY | $2.0B |
EWEDWARDS LIFESCIENCES CORP | $1.2B |
RVMDREVOLUTION MEDICINES INC | $448.0M |
PRAXPRAXIS PRECISION MEDICINES I | $322.5M |
UTHUNITED THERAPEUTICS CORP DEL | $247.6M |
CELCCELCUITY INC | $151.8M |
LNTHLANTHEUS HLDGS INC | $83.5M |
BUWABIO RAD LABS INC | $66.4M |
BLTEBELITE BIO INC | $55.0M |
TOIIWTHE ONCOLOGY INSTITUTE INC | $51.0M |
ALNYALNYLAM PHARMACEUTICALS INC | $20.5M |
CHECHEMED CORP NEW | $14.0M |
PMVPPMV PHARMACEUTICALS INC | $11.8M |
SRZNWSURROZEN INC | $2.8M |
MIRMMIRUM PHARMACEUTICALS INC | $706K |
HUMHUMANA INC | $364K |